Why is there such disparity in who dies of breast cancer?
Recently, a much needed $12 million research project was financed by the National Cancer Institute (NCI) to study whether or not genetics or other dynamics make a difference in the fatalities witnessed gap of African-American and other women within the U.S.According to huffingtonpost
At present, cases of breast cancer within African-American women make up 40 percent of those who become fatal. When examining the declining rates of mortality since 1990, African-American women’s treatment didn’t shrink nearly as much.
And again, it begs the question: why?
As the head of the leading association which has invested nearly $50 million in search of improved treatments and the cure to breast cancer, Judith Salerno continues to seek out solutions to this question- although everyone fathoms the difficulties.
Judith Salerno works with the National Cancer Institute (NCI) along with Susan G. Komen, where she is the president and CEO, as well as other groups, focused on cancers; it’s been understood for some time that a person’s genes play a part in how their life unfolds. Different groups of women are diagnosed with various types and subtypes of the disease. One such subtype, African-Americans, tend to be identified with triple negative breast cancer, whereby the negative refers to 3 distinct tumor indication: one progesterone and one estrogen receptor, and HER2 (which presently has no treatment). Additionally, these women tend to become cancerous much earlier in life, which sets off a quicker ticking time bomb.
By advancing our grasp of such distinctive traits of the mounting cancer growths within these women; surely playing all cancer patients survival collectively in the future.
It’s believed that one-third of women who are presently dying of breast cancer, yes as much as one-third may not have to lose their lives if a significant medical leap forward arises. Except that even if a cure is discovered, or an exceptional treatment is developed both are useless unless they can be used by the patients that desperately need them. Susan G. Komen seeks a day when all cancer healthcare is accessible to any who need it.
A joint method has been devised to improve access in addition to medical investment studies thus improving the current generation of women and eliminating the cancer gap among all people forever. This method is at the heart of Susan G. Komen’s statewide proposal for health impartiality, which was commenced in 2015 in order to decrease breast cancer fatalities.
Susan G. Komen’s first concern is eliminating a woman’s fear, especially of having to avoid screening simply because they cannot afford treatment plus the rent.
However, there are other issues in play as well, as a result of countless meetings with communities assisting with the proposal- much as been discovered, just as how every population is individual, there are still common barriers. Some of these barriers include: the quality of screening, delays in follow-up, denial and abuse of treatment, the level of medical education focused on genetics; let alone addressing child care so a woman can meet with doctors, having to miss work, and a big hurdle- meeting costly travel expenses.
No longer will these barriers be tolerated, Susan G. Komen seeks to help wherever it can to guarantee that all women can access adequate assets make breast cancer a thing of the past.